PPARG and type 2 diabetes mellitus: Potential drugs can be divided into PPAR-γ agonist, β3-AR agonist, insulin sensitizer, insulin, and lipase clearing factor stimulant, acting on signaling pathway including “PPAR signaling pathway”, “adipocytokine signaling pathway”, “insulin signaling pathway”, and “type II diabetes mellitus” (Table 2).